← Back to Patent Explorer
EP0276131A2 Expired / Lapsed EP ⏱️ 0.0 years remaining

Non-natural demethylavermectins and process therefor

Assignee: Pfizer Inc
•
Filing: 1988-01-20
•
Granted: —
•
Expires: 2008-01-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Non-natural demethylavermectins useful as parasiticides and process therefor.

Inventors

  • 👤 Edmund William Hafner
  • 👤 Kelvin Scott Holdom
  • 👤 Shih-Jen Edward Lee

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-11-09 03:35
CPC Classifications
C; C07; C07D; C07D493/00; C07D493/22; C07H; C07H19/00; C07H19/01; A; A01; A01N; A01N43/00; A01N43/90; A61; A61P; A61P33/00; A61P33/10; C07H19/02; C12; C12N; C12N1/00; C12N1/20; C12N1/205; C12P; C12P19/00; C12P19/44; C12P19/60; C12P19/62; C12P19/623; C12R; C12R2001/00; C12R2001/01; C12R2001/465

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 241 words
A compound for preparation of a compound of the formula: wherein the broken line at the 22-23 position represents an optional double bond; R¹ is H or OH and the double bond is absent, or, the double bond is present and R¹ is absent; R is an alpha-branched C₃-C₈ alkyl, alkenyl, alkynyl, alkoxyalkyl or alkylthioalkyl group; a C₅-C₈ cycloalkylalkyl group wherein the alkyl group is an alpha-branched C₂-C₅ alkyl group; a C₃-C₈ cycloalkyl or C₅-C₈ cycloalkenyl group, either of which may optionally be substituted by methylene or one or more C₁-C₄ alkyl groups or halo atoms; or a 3 to 6 membered oxygen or sulfur containing heterocyclic ring which may be saturated, or fully or partially unsaturated and which may optionally be substituted by one or more C₁-C₄ alkyl groups or halo atoms; with the proviso that when R is alkyl, it is not isopropyl or sec-butyl; R² is a disaccharide moiety of the formula where each of R⁴ and R⁵ is hydrogen or methyl, with the proviso that at least one of R⁴ and R⁵ is hydrogen; and R³ is hydrogen or methyl;which comprises aerobically fermenting in the presence of sinefungin with a strain of streptomyces avermitilis which lacks one or both of branched-chain 2-oxo acid dehydrogenase activity and branched-chain amino acid transaminase activity, an aqueous nutrient medium comprising an assimilable source of nitrogen, carbon and inorganic salts and a compound capable of utilization in the biosynthesis of an avermectin.
Claim 2
Dependent Claim 241 words
A compound for preparation of a compound of the formula: wherein the broken line at the 22-23 position represents an optional double bond; R¹ is H or OH and the double bond is absent, or, the double bond is present and R¹ is absent; R is an alpha-branched C₃-C₈ alkyl, alkenyl, alkynyl, alkoxyalkyl or alkylthioalkyl group; a C₅-C₈ cycloalkylalkyl group wherein the alkyl group is an alpha-branched C₂-C₅ alkyl group; a C₃-C₈ cycloalkyl or C₅-C₈ cycloalkenyl group, either of which may optionally be substituted by methylene or one or more C₁-C₄ alkyl groups or halo atoms; or a 3 to 6 membered oxygen or sulfur containing heterocyclic ring which may be saturated, or fully or partially unsaturated and which may optionally be substituted by one or more C₁-C₄ alkyl groups or halo atoms; with the proviso that when R is alkyl, it is not isopropyl or sec-butyl; R² is a disaccharide moiety of the formula where each of R⁴ and R⁵ is hydrogen or methyl, with the proviso that at least one of R⁴ and R⁵ is hydrogen; and R³ is hydrogen or methyl;which comprises aerobically fermenting in the presence of sinefungin with a strain of streptomyces avermitilis which lacks one or both of branched-chain 2-oxo acid dehydrogenase activity and branched-chain amino acid transaminase activity, an aqueous nutrient medium comprising an assimilable source of nitrogen, carbon and inorganic salts and a compound capable of utilization in the biosynthesis of an avermectin.
Claim 3
Dependent Claim 45 words
A process according to claim 1 wherein the compound capable of utilization in the biosynthesis of an avermectin is an acid of the formula R-COOH or a compound convertible to said acid by S . avermitilis , wherein R is other than isopropyl or (S)-sec-butyl.
Claim 4
Dependent Claim 21 words
A process according to claim 1, wherein the S . avermitilis has the identifying characteristics of ATCC 53567 or ATCC 53568.
Claim 5
Dependent Claim 56 words
A process according to claim 1 wherein the compound is of the formula R-COOH wherein R is an alpha-branched-chain group, the carbon atom thereof to which is attached the -COOH group is also attached to at least two other atoms or groups other than hydrogen; or a compound convertible to said compound during the fermentation process.
Claim 6
Dependent Claim 107 words
A process according to claim 4 wherein R is an alpha-branched C₃-C₈ alkyl, alkenyl, alkynyl, alkoxy-alkyl or alkylthioalkyl group; a C₅-C₈ cycloalkylalkyl group wherein the alkyl group is an alpha-branched C₂-C₅ alkyl group; a C₃-C₈ cycloalkyl or C₅-C₈ cycloalkenyl group, either of which may optionally be substituted by methylene or one or more C₁-C₄ alkyl groups or halo atoms; or a 3 to 6 membered oxygen or sulfur containing heterocyclic ring which may be saturated, or fully or partially unsaturated and which may optionally be substituted by one or more C₁-C₄ alkyl groups or halo atoms, or a compound convertible to said compound during the fermentation process.
Claim 7
Dependent Claim 83 words
A process according to claim 4 wherein the compound convertible to substrate RCOOH is R-(CH₂) n -Z wherein R is as previously defined; n is 0, 2, 4 or 6; and Z is -CH₂OH, -CHO, -COOR⁵, -CH₂NH₂ or -CONHR⁶ wherein R⁵ is H or (C 1-6 )alkyl; R⁶ is hydrogen, (C 1-4 )alkyl, -CH(COOH)CH₂COOH, -CH(COOH) (CH₂)₂COOH or -CH (COOH) (CH₂)₂SCH₃ or, when the strain of S . avermitilis lacks only branched-chain amino acid transaminase activity, the compound convertible to substrate RCOOH is R-CO-Z.
Claim 8
Dependent Claim 46 words
A process according to claim 5 wherein R is cyclobutyl cyclopentyl cyclohexyl cycloheptyl 2-methylcyclopropyl 3-cyclohexenyl 1-cyclopentenyl 1-cyclohexenyl 3-methylcyclohexyl (cis/trans) 4-methylenecyclohexyl 3-methylcyclobutyl 3-methylenecyclobutyl 3-cyclopentenyl 1-cyclopropylethyl 3-fluorocyclobutyl 4,4-difluorocyclohexyl isopropyl sec-butyl 2-pentyl 2,3-dimethylpropyl 2-hexyl 2-pent-4-enyl 2-methylthioethyl S-2-pentyl R-2-pentyl 2-thienyl 3-thienyl 4-tetrahydropyranyl 3-furyl 2-chlorothienyl 3-tetrahydrothienyl 4-methylthio-2-butyl 4-tetrahydrothiopyranyl 4-methoxy-2-butyl or 4-methylthio-2-butyl.
Claim 9
Dependent Claim 15 words
A process according to claim 7 wherein R is cyclopentyl, cyclohexyl, 3-thienyl, 3-furyl or 1-methylthioethyl.
Claim 10
Dependent Claim 21 words
A process according to claim 5 wherein when R is an alpha-branched C₃-C₈ alkyl group, it is not isopropyl or (S)-sec-butyl.
Claim 11
Dependent Claim 28 words
A composition for the treatment and prevention of parasitic infections in humans and animals which comprises a compound of claim 1 together with an inert diluent or carrier.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag